Dysregulation of Ubiquitination in Renal Cell Carcinoma
Author Information
Author(s): You Hongjie, Zhang Hui, Jin Xiaofeng, Yan Zejun
Primary Institution: Department of Urology, The First Affiliated Hospital of Ningbo University, Ningbo University, Ningbo, Zhejiang, China
Hypothesis
Dysregulation of ubiquitination modifications is associated with the occurrence and development of renal cell carcinoma (RCC).
Conclusion
Targeting components of the ubiquitination modification pathway represents a promising strategy for RCC treatment.
Supporting Evidence
- Dysregulation of ubiquitination is linked to various signaling pathways involved in RCC.
- E3 ubiquitin ligases and deubiquitinases play critical roles in the regulation of protein stability.
- Targeting ubiquitination pathways may improve treatment outcomes for RCC patients.
Takeaway
This study talks about how problems with a process called ubiquitination can lead to kidney cancer and suggests new ways to treat it.
Methodology
This is a review article summarizing various studies on the role of ubiquitination in RCC.
Limitations
The review does not provide original experimental data and relies on existing literature.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website